Hematopoiesis & Alzheimer's Disease

The formation of blood cells, hematopoiesis, has been exploited for the potential use as a therapy in Alzheimer’s disease. Decreased levels of lymphocytes and proteins involved in stem cell recruitment are found in early stages of Alzheimer’s disease. Here is the latest research on hematopoiesis and Alzheimer’s disease.

June 26, 2020
Open Access

The Source and Dynamics of Adult Hematopoiesis: Insights from Lineage Tracing

Annual Review of Cell and Developmental Biology
Joseph N PucellaBoris Reizis
July 1, 2020

Somatic mutation of the V617F JAK2 gene in patients of the cardiovascular diseases

Terapevticheskiĭ arkhiv
I A OlkhovskiyT L Martsinkevich
July 8, 2020
Review

Autoimmunity, Clonal Hematopoiesis, and Myeloid Neoplasms

Rheumatic Diseases Clinics of North America
Delamo I Bekele, Mrinal M Patnaik
June 24, 2020

Biologically-based models of cancer risk in radiation research

International Journal of Radiation Biology
Jan Christian KaiserGeorgios T Stathopoulos
June 18, 2020
Review
Open Access

Nucleophosmin 1 Mutations in Acute Myeloid Leukemia

Genes
Jabra ZarkaGhayas C Issa
July 1, 2020

Effect of Aging and 5-Fluorouracil Treatment on Bone Marrow Stem Cell Dynamics

Stem Cell Reviews and Reports
Ranita GangulyDeepa Bhartiya
June 20, 2020
Open Access

The genomic and epigenomic evolutionary history of papillary renal cell carcinomas

Nature Communications
Bin ZhuMaria Teresa Landi
June 14, 2020
Open Access

Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant

Nature Communications
Tarek H MouhieddineIrene M Ghobrial
July 10, 2020
Review
Open Access

Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia

Genes
Alexandra Higgins, Mithun Vinod Shah
July 7, 2020
Open Access

Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

American Journal of Hematology
Rose-Marie AminiPanagiotis Baliakas
June 27, 2020

Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma

Blood Advances
Christopher K RushtonRyan D Morin
June 26, 2020
Open Access

Clonal hematopoiesis in myeloma: root of all maladies!

Blood
Paola Neri
July 1, 2020

Multiple Somatic Mutations for Clonal Hematopoiesis Are Associated with Increased Mortality in Patients with Chronic Heart Failure

Circulation. Genomic and Precision Medicine
Sebastian CremerAndreas M Zeiher

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/hematopoiesis-alzheimers-disease/a821b3fb-abb7-4dfe-9f5e-76a90e512a94